Compare
02/22/2025 2025-02-22 23:41Compare
| Deverra Fine with lidocaine remove | Bellast Soft L remove | Miracle L remove | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Name | Deverra Fine with lidocaine remove | Bellast Soft L remove | Miracle L remove | ||||||
| Image |  |  |  | ||||||
| SKU | FM-02-552640 | FM-02-26122 | FM-10-26799 | ||||||
| Rating | |||||||||
| Price | $31.00 | $35.00 | $269.00 | ||||||
| Stock | |||||||||
| Availability | |||||||||
| Add to cart | |||||||||
| Description | |||||||||
| Content | Deverra Fine with lidocaine – Aesthetic Products Injectable Deverra Fine with lidocaine is a lightweight aesthetic product designed for fine wrinkle correction and subtle enhancements. Its smooth formulation ensures precision, while lidocaine maximizes patient comfort during treatment. Key Benefits
Professional Use OnlyDeverra Fine with lidocaine must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | Bellast Soft L – Other Injectable Bellast Soft L is an aesthetic product crafted for hydration and rejuvenation. It supports skin health and elasticity. Key Benefits
Professional Use OnlyBellast Soft L must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | Miracle L – Mesotherapy Injectable Miracle L is a hydrating dermal filler formulated to improve skin elasticity and glow. It revitalizes texture and enhances natural softness. Key Benefits
Professional Use OnlyMiracle L must be administered exclusively by licensed medical professionals or certified aesthetic practitioners. Dosage and injection sites should be customized to each patient’s needs. Additional InformationCountry of Origin: Korea | ||||||
| Weight | N/A | N/A | N/A | ||||||
| Dimensions | N/A | N/A | N/A | ||||||
| Additional information |
|
|
|
